These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 30640748)

  • 41. Oppositional defiant disorder in adults with ADHD.
    Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
    J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder.
    Oner P; Oner O; Cop E; Munir KM
    Klinik Psikofarmakol Bulteni; 2012; 22(4):325-331. PubMed ID: 28804252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD.
    Masi G; Fantozzi P; Muratori P; Bertolucci G; Tacchi A; Villafranca A; Pfanner C; Cortese S
    Compr Psychiatry; 2020 Jul; 100():152178. PubMed ID: 32386957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder.
    Salatino-Oliveira A; Genro JP; Zeni C; Polanczyk GV; Chazan R; Guimarães AP; Callegari-Jacques SM; Rohde LA; Hutz MH
    Biol Psychiatry; 2011 Aug; 70(3):216-21. PubMed ID: 21550019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
    Baziar S; Aqamolaei A; Khadem E; Mortazavi SH; Naderi S; Sahebolzamani E; Mortezaei A; Jalilevand S; Mohammadi MR; Shahmirzadi M; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):205-212. PubMed ID: 30741567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
    Connor DF; Barkley RA; Davis HT
    Clin Pediatr (Phila); 2000 Jan; 39(1):15-25. PubMed ID: 10660814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
    Pearson DA; Santos CW; Aman MG; Arnold LE; Casat CD; Mansour R; Lane DM; Loveland KA; Bukstein OG; Jerger SW; Factor P; Vanwoerden S; Perez E; Cleveland LA
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):337-51. PubMed ID: 23782128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia.
    Golubchik P; Sever J; Weizman A
    Int Clin Psychopharmacol; 2014 Jul; 29(4):212-5. PubMed ID: 24448460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of methylphenidate on sustained attention among adolescents with attention-deficit hyperactivity disorder.
    Lufi D; Bassin-Savion S; Rubel L
    Neurocase; 2015; 21(6):802-8. PubMed ID: 25771849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate.
    Elliott GR; Blasey C; Rekshan W; Rush AJ; Palmer DM; Clarke S; Kohn M; Kaplan C; Gordon E
    J Atten Disord; 2017 Dec; 21(14):1151-1160. PubMed ID: 25122732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of parent training in combination with methylphenidate treatment on family relationships for children with attention deficit/hyperactivity disorder].
    Zhang Y; Kang CY; Zhao XR; Xuan X; Ding KJ; Liu RX; Wang YJ; Yang RX; Li XR; Wan S
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):185-9. PubMed ID: 24568915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.